505 related articles for article (PubMed ID: 17064684)
21. Effects of angiotensin II AT1 receptor inhibition and exercise training on insulin action in rats on high-fat diet.
Wang Z; Koike T; Li P; Jiang H; Natsume Y; Mu L; Chen T; Oshida Y
Life Sci; 2012 Feb; 90(9-10):322-7. PubMed ID: 22210187
[TBL] [Abstract][Full Text] [Related]
22. Candesartan cilexetil on regular hemodialysis: inability to reduce excessive thirst, but good tolerance and efficacy in hypertensive patients.
Rostoker G; Griuncelli M; Benmaadi A
Ren Fail; 2006; 28(4):283-6. PubMed ID: 16771242
[TBL] [Abstract][Full Text] [Related]
23. Chronic AT
Rodriguez R; Lee AY; Godoy-Lugo JA; Martinez B; Ohsaki H; Nakano D; Parkes DG; Nishiyama A; Vázquez-Medina JP; Ortiz RM
Am J Physiol Endocrinol Metab; 2021 Nov; 321(5):E714-E727. PubMed ID: 34658252
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action.
Inada Y; Ojima M; Kanagawa R; Misumi Y; Nishikawa K; Naka T
J Hum Hypertens; 1999 Jan; 13 Suppl 1():S75-80. PubMed ID: 10076925
[TBL] [Abstract][Full Text] [Related]
25. Reduction of bleomycin induced lung fibrosis by candesartan cilexetil, an angiotensin II type 1 receptor antagonist.
Otsuka M; Takahashi H; Shiratori M; Chiba H; Abe S
Thorax; 2004 Jan; 59(1):31-8. PubMed ID: 14694243
[TBL] [Abstract][Full Text] [Related]
26. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
27. Effects of AT1 receptor antagonist on proteoglycan gene expression in hypertensive rats.
Sasamura H; Shimizu-Hirota R; Nakaya H; Saruta T
Hypertens Res; 2001 Mar; 24(2):165-72. PubMed ID: 11325076
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan.
Azizi M; Chatellier G; Guyene TT; Ménard J
J Hypertens; 1999 Apr; 17(4):561-8. PubMed ID: 10404959
[TBL] [Abstract][Full Text] [Related]
29. Effects of candesartan cilexetil on oxidative state and renal function in 5/6 nephrectomized rats.
Sugimoto K; Tsuruoka S; Matsushita K; Fujimura A
J Hum Hypertens; 1999 Jan; 13 Suppl 1():S63-70; discussion S81. PubMed ID: 10076923
[TBL] [Abstract][Full Text] [Related]
30. Oral administration of candesartan improves the survival of mice with viral myocarditis through modification of cardiac adiponectin expression.
Saegusa S; Fei Y; Takahashi T; Sumino H; Moriya J; Kawaura K; Yamakawa J; Itoh T; Morimoto S; Nakahashi T; Iwai K; Matsumoto M; Kanda T
Cardiovasc Drugs Ther; 2007 Jun; 21(3):155-60. PubMed ID: 17484035
[TBL] [Abstract][Full Text] [Related]
31. Differential clinical profile of candesartan compared to other angiotensin receptor blockers.
Cernes R; Mashavi M; Zimlichman R
Vasc Health Risk Manag; 2011; 7():749-59. PubMed ID: 22241949
[TBL] [Abstract][Full Text] [Related]
32. Renocortical expression of renin and of cyclooxygenase-2 in response to angiotensin II AT1 receptor blockade is closely coordinated but not causally linked.
Höcherl K; Wolf K; Castrop H; Ittner KP; Bucher M; Kees F; Grobecker HF; Kurtz A
Pflugers Arch; 2001 Sep; 442(6):821-7. PubMed ID: 11680613
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of imidapril and candesartan cilexetil on plasminogen activator inhibitor-1 expression induced by prolonged inhibition of nitric oxide synthesis in rat hearts.
Katoh M; Egashira K; Mitsui T; Takeshita A; Narita H
J Cardiovasc Pharmacol; 2000 Jun; 35(6):932-6. PubMed ID: 10836729
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin receptor gene expression in candesartan mediated neuroprotection.
Lu Q; Zhu YZ; Wong PT
Neuroreport; 2004 Dec; 15(17):2643-6. PubMed ID: 15570169
[TBL] [Abstract][Full Text] [Related]
35. [Candesartan cilexetil: pharmacological properties and protective effects against organ damage of a novel nonpeptide angiotensin II-receptor antagonist].
Inada Y; Naka T
Nihon Yakurigaku Zasshi; 2000 Mar; 115(3):151-60. PubMed ID: 10876800
[TBL] [Abstract][Full Text] [Related]
36. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.
Nishiyama A; Yoshizumi M; Rahman M; Kobori H; Seth DM; Miyatake A; Zhang GX; Yao L; Hitomi H; Shokoji T; Kiyomoto H; Kimura S; Tamaki T; Kohno M; Abe Y
Kidney Int; 2004 Mar; 65(3):972-81. PubMed ID: 14871417
[TBL] [Abstract][Full Text] [Related]
37. AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats.
Zhou J; Pavel J; Macova M; Yu ZX; Imboden H; Ge L; Nishioku T; Dou J; Delgiacco E; Saavedra JM
Stroke; 2006 May; 37(5):1271-6. PubMed ID: 16601219
[TBL] [Abstract][Full Text] [Related]
38. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
[TBL] [Abstract][Full Text] [Related]
39. Effects of AT1 receptor antagonist and spironolactone on cardiac expression of ET-1 mRNA in SHR-SP/Izm.
Naruse M; Tanabe A; Hara Y; Takagi S; Imaki T; Takano K
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S1-3. PubMed ID: 15838251
[TBL] [Abstract][Full Text] [Related]
40. Cadmium reduces adipocyte size and expression levels of adiponectin and Peg1/Mest in adipose tissue.
Kawakami T; Sugimoto H; Furuichi R; Kadota Y; Inoue M; Setsu K; Suzuki S; Sato M
Toxicology; 2010 Jan; 267(1-3):20-6. PubMed ID: 19666079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
